From: Effect of ketotifen premedication on adverse reactions during peanut oral immunotherapy
Clinical characteristic | Ketotifen group | Placebo group |
---|---|---|
Number | 4 | 2 |
Median Age (years) | 10 | 10 |
Sex | 1 female, 3 male | 1 female, 1 male |
History of asthma | 2/4 | 1/2 |
History of allergic rhinitis | 1/4 | 0/2 |
History of atopic dermatitis | 2/4 | 0/2 |
History of other food allergy | 1/4 | 1/2 |
Initial median size (mm) of peanut skin prick test, (range) | 10 (7–16) | 15 (15) |
Initial median peanut specific IgE (kUA/L), (range) | >100 kU/L (44.9 - >100) | >100 kU/L (>100) |